Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66951 - 66975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	CAV1	857	upregulated	rosiglitazone results in increased expression of CAV1 mRNA	7q31.2	A22612 A20966
Rosiglitazone	Approved Investigational	CBS	875	downregulated	rosiglitazone results in decreased expression of CBS mRNA	21q22.3	A22609
Rosiglitazone	Approved Investigational	CCL3	6348	downregulated	rosiglitazone results in decreased expression of CCL3 mRNA	17q12	A23178
Rosiglitazone	Approved Investigational	CCNC	892	downregulated	rosiglitazone results in decreased expression of CCNC mRNA	6q16.2	A24100
Rosiglitazone	Approved Investigational	CCND1	595	downregulated	rosiglitazone results in decreased expression of CCND1 mRNA	11q13.3	A20877
Rosiglitazone	Approved Investigational	CCNL1	57018	downregulated	rosiglitazone results in decreased expression of CCNL1 mRNA	3q25.31	A24100
Rosiglitazone	Approved Investigational	CCT2	10576	upregulated	rosiglitazone results in increased expression of CCT2 mRNA	12q15	A22609
Rosiglitazone	Approved Investigational	CD1A	909	downregulated	rosiglitazone results in decreased expression of CD1A mRNA	1q23.1	A10216
Rosiglitazone	Approved Investigational	CD1D	912	upregulated	rosiglitazone results in increased expression of CD1D mRNA	1q23.1	A10216
Rosiglitazone	Approved Investigational	CD300A	11314	upregulated	rosiglitazone results in increased expression of CD300A mRNA	17q25.1	A10216
Rosiglitazone	Approved Investigational	CD300LB	124599	upregulated	rosiglitazone results in increased expression of CD300LB mRNA	17q25.1	A10216
Rosiglitazone	Approved Investigational	CD300LF	146722	upregulated	rosiglitazone results in increased expression of CD300LF mRNA	17q25.1	A10216
Rosiglitazone	Approved Investigational	CD36	948	upregulated	rosiglitazone results in increased expression of CD36 mRNA	7q21.11	A24108 A23649 A24109 A20966 A23178 A22609 A24110
Rosiglitazone	Approved Investigational	CD70	970	upregulated	rosiglitazone results in increased expression of CD70 mRNA	19p13.3	A22609
Rosiglitazone	Approved Investigational	CDC20B	166979	downregulated	rosiglitazone results in decreased expression of CDC20B mRNA	5q11.2	A22609
Rosiglitazone	Approved Investigational	CDH1	999	upregulated	rosiglitazone results in increased expression of CDH1 mRNA	16q22.1	A20877
Rosiglitazone	Approved Investigational	CDK4	1019	upregulated	rosiglitazone results in increased expression of CDK4 mRNA	12q14.1	A24100
Rosiglitazone	Approved Investigational	CDK6	1021	downregulated	rosiglitazone results in decreased expression of CDK6 mRNA	7q21.2	A20427
Rosiglitazone	Approved Investigational	CDK7	1022	downregulated	rosiglitazone results in decreased expression of CDK7 mRNA	5q13.2	A24100
Rosiglitazone	Approved Investigational	CDKN1A	1026	upregulated	rosiglitazone results in increased expression of CDKN1A mRNA	6p21.2	A24100
Rosiglitazone	Approved Investigational	CDR2L	30850	downregulated	rosiglitazone results in decreased expression of CDR2L mRNA	17q25.1	A10216
Rosiglitazone	Approved Investigational	CES1	1066	upregulated	rosiglitazone results in increased expression of CES1 mRNA	16q12.2	A23649
Rosiglitazone	Approved Investigational	CETN3	1070	downregulated	rosiglitazone results in decreased expression of CETN3 mRNA	5q14.3	A24100
Rosiglitazone	Approved Investigational	CFB	629	downregulated	rosiglitazone results in decreased expression of CFB mRNA	6p21.33	A22609
Rosiglitazone	Approved Investigational	CFH	3075	downregulated	rosiglitazone results in decreased expression of CFH mRNA	1q31.3	A22609

Displaying entries 66951 - 66975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability